Werth VP - Search Results

1

Nomenclature of Cutaneous Vasculitis: Dermatologic Addendum to the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Sunderkötter CH, Zelger B, Chen KR, Requena L, Piette W, Carlson JA, Dutz J, Lamprecht P, Mahr A, Aberer E, Werth VP, Wetter DA, Kawana S, Luqmani R, Frances C, Jorizzo J, Watts JR, Metze D, Caproni M, Alpsoy E, Callen JP, Fiorentino D, Merkel PA, Falk RJ, Jennette JC. Sunderkötter CH, et al. Among authors: werth vp. Arthritis Rheumatol. 2018 Feb;70(2):171-184. doi: 10.1002/art.40375. Arthritis Rheumatol. 2018. PMID: 29136340 Review.

2

Pathogenetic mechanisms and treatment of cutaneous lupus erythematosus.

Werth VP, Dutz JP, Sontheimer RD. Werth VP, et al. Curr Opin Rheumatol. 1997 Sep;9(5):400-9. doi: 10.1097/00002281-199709000-00005. Curr Opin Rheumatol. 1997. PMID: 9309195 Review.

3

Leukocytoclastic vasculitis due to etanercept.

Galaria NA, Werth VP, Schumacher HR. Galaria NA, et al. Among authors: werth vp. J Rheumatol. 2000 Aug;27(8):2041-4. J Rheumatol. 2000. PMID: 10955351

4

Associations of tumor necrosis factor alpha and HLA polymorphisms with adult dermatomyositis: implications for a unique pathogenesis.

Werth VP, Callen JP, Ang G, Sullivan KE. Werth VP, et al. J Invest Dermatol. 2002 Sep;119(3):617-20. doi: 10.1046/j.1523-1747.2002.01869.x. J Invest Dermatol. 2002. PMID: 12230503 Free article.

5

Mannose binding lectin (MBL) polymorphisms associated with low MBL production in patients with dermatomyositis.

Werth VP, Berlin JA, Callen JP, Mick R, Sullivan KE. Werth VP, et al. J Invest Dermatol. 2002 Dec;119(6):1394-9. doi: 10.1046/j.1523-1747.2002.19608.x. J Invest Dermatol. 2002. PMID: 12485445 Free article.

6

Dermatology position paper on the revision of the 1982 ACR criteria for systemic lupus erythematosus.

Albrecht J, Berlin JA, Braverman IM, Callen JP, Connolly MK, Costner MI, Dutz J, Fivenson D, Franks AG, Jorizzo JL, Lee LA, McCauliffe DP, Sontheimer RD, Werth VP. Albrecht J, et al. Among authors: werth vp. Lupus. 2004;13(11):839-49. doi: 10.1191/0961203304lu2020oa. Lupus. 2004. PMID: 15580979

7

Pathophysiology of cutaneous lupus erythematosus.

Lin JH, Dutz JP, Sontheimer RD, Werth VP. Lin JH, et al. Among authors: werth vp. Clin Rev Allergy Immunol. 2007 Oct;33(1-2):85-106. doi: 10.1007/s12016-007-0031-x. Clin Rev Allergy Immunol. 2007. PMID: 18094949 Review.

8

Dermatomyositis.

Krathen MS, Fiorentino D, Werth VP. Krathen MS, et al. Among authors: werth vp. Curr Dir Autoimmun. 2008;10:313-32. doi: 10.1159/000131751. Curr Dir Autoimmun. 2008. PMID: 18460893 Free PMC article. Review.

9

Modification of the cutaneous dermatomyositis disease area and severity index, an outcome instrument.

Yassaee M, Fiorentino D, Okawa J, Taylor L, Coley C, Troxel AB, Werth VP. Yassaee M, et al. Among authors: werth vp. Br J Dermatol. 2010 Mar;162(3):669-73. doi: 10.1111/j.1365-2133.2009.09521.x. Epub 2009 Oct 26. Br J Dermatol. 2010. PMID: 19863510 Free PMC article.

10

Dermatomyositis autoantibodies: clinical markers of patients past, present, and future.

Fiorentino D, Werth VP. Fiorentino D, et al. Among authors: werth vp. Arch Dermatol. 2011 Apr;147(4):492-4. doi: 10.1001/archdermatol.2011.41. Arch Dermatol. 2011. PMID: 21482900 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

441 results

Search Page